Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Inside the Lab Microbiology and immunology, Point of care testing, Microbiology and immunology, Clinical care, Technology and innovation

Infectious Disease Detective

Infectious Disease Detective

A blood test to quickly decide if a viral or bacterial infection is the culprit causing disease could aid the quest to cut down on antibiotic misuse

By Kfir Oved and Eran Eden

At a Glance

  • Antibiotic resistance is a growing problem which has many experts worried, with a variety of possible solutions being put forward
  • Identifying which patients have a bacterial infection and which have a virus using a blood test could help physicians make informed decisions on treatment
  • An ELISA-based test that computationally integrates the measurements of several circulating host-proteins showed high accuracy in clinical studies and is being piloted n several hospitals
  • A point-of-care platform and further clinical studies are planned to expand application to make it more accessible

The worrying problem of antibiotic resistance is frequently in the news, with global health forecasts over the last few years looking decidedly gloomy. Today, such predictions are becoming reality, and in some cases the situation is even worse than what was foreseen – the World Health Organization has named antimicrobial resistance a major threat to public health. A key factor in the rising resistance rates is antibiotic misuse. However, it must be acknowledged that misuse is not simply due to irresponsible prescribing, and is often driven by the difficulty in ascertaining the cause of the disease – bacteria or virus – especially in the early stages. The symptoms of many illnesses are similar, and lab tests such as C-reactive protein (CRP) or white blood cell count just aren’t accurate enough to tell apart bacterial and viral infections.

Read the full article now

Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Authors

Kfir Oved

Kfir Oved is a co-founder and CTO of MeMed, a biotechnology company based in Israel.


Eran Eden

Eran Eden is co-founder and CEO of MeMed, a biotechnology company based in Israel.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register